Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development.

Keywords

Medicine, BRCA mutation, Prophylactic Surgery, Radical surgery, Oophorectomy

References

• Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy嘉高 近藤, 弥生 加賀美, 節子 半田 — 2009
• Increased cardiovascular mortality following early bilateral oophorectomyCathleen M. Rivera, Brandon R. Grossardt, Deborah J. Rhodes — 2009
• Shortened Telomeres in Serous Tubal Intraepithelial Carcinoma: An Early Event in Ovarian High-grade Serous CarcinogenesisElisabetta Kuhn, Alan K. Meeker, Tian‐Li Wang — 2010
• The Origin of Ovarian Carcinomas: A Unifying HypothesisNelly Auersperg — 2011
• Multistep Level Sections to Detect Occult Fallopian Tube Carcinoma in Risk-reducing Salpingo-oophorectomies From Women With BRCA Mutations: Implications for Defining an Optimal Specimen Dissection ProtocolJoseph T. Rabban, Ellen Krasik, Lee-may Chen — 2009
• Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.Mark E. Robson, Martee L. Hensley, Richard R. Barakat — 2003
• Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health StudyWilliam H. Parker, Michael S. Broder, Eunice Chang — 2009
• The genesis and evolution of high-grade serous ovarian cancerDavid D.L. Bowtell — 2010
• The Fallopian Tube-Peritoneal Junction: A Potential Site of CarcinogenesisJeffrey D. Seidman, Anna Yemelyanova, Richard J. Zaino — 2011
• The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer SyndromeFabíola Medeiros, Michael G. Muto, Yonghee Lee — 2006
• Intercepting early pelvic serous carcinoma by routine pathologic examination of the fimbriaDana R Semmel, Ann K. Folkins, Michelle S. Hirsch — 2009
• Fatigue and Quality of Life After Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Hereditary Breast-Ovarian CancerTrond Melbye Michelsen, Anne Dørum, Claes G. Tropé — 2009
• "Primary peritoneal" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer.Jeffrey D. Seidman, Po Zhao, Anna Yemelyanova — 2011
• Does Bilateral Salpingectomy with Ovarian Retention Warrant Consideration as a Temporary Bridge to Risk-Reducing Bilateral Oophorectomy in BRCA1/2 Mutation Carriers?Mark H. Greene, Phuong L. Mai, Peter E. Schwartz — 2010
• Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.Amy Finch, Patricia Shaw, Barry P. Rosen — 2006
• Advances in the Recognition of Tubal Intraepithelial Carcinoma: Applications to Cancer Screening and the Pathogenesis of Ovarian CancerYonghee Lee, Fabíola Medeiros, David W. Kindelberger — 2006
• Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous CancerChristopher P. Crum, Ronny Drapkin, David W. Kindelberger — 2007
• Transitional Cell Metaplasia of Fallopian Tube Fimbriae: A Potential Mimic of Early Tubal Carcinoma in Risk Reduction Salpingo-oophorectomies From Women With BRCA MutationsJoseph T. Rabban, Beth Crawford, Lee-may Chen — 2009
• Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?Ilana Cass, Ann E. Walts, Beth Y. Karlan — 2010
• Serous Tubal Intraepithelial Carcinoma and the Dominant Ovarian Mass: Clues to Serous Tumor Origin?Michael H. Roh, David W. Kindelberger, Christopher P. Crum — 2009

Cited by

• Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options.María José Villaverde — 2013
• Risk‐reducing early salpingectomy and delayed oophorectomy as a two‐staged alternative for primary prevention of ovarian cancer in women at increased risk: a commentaryScott Tarvainen — 2019
• Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.Dana Meaney‐Delman, Cecelia Bellcross — 2013
• Prophylactic Salpingectomy and Delayed Oophorectomy as an Alternative for BRCA Mutation CarriersJanice S. Kwon, Anna V. Tinker, Gary Pansegrau — 2013
• Breast Cancer Risk-reducing Strategies in BRCA1/2 Mutation CarriersB.A.M. Heemskerk-Gerritsen — 2014
• Premalignancies of serous ovarian cancer in Müllerian derived epitheliumMarjanka J.J.M. Mingels — 2015
• Präventive operative Optionen für Frauen mit einer familiären Brust- und EierstockkrebsbelastungKerstin Rhiem — 2015
• Chirurgie annexielle prophylactique des femmes à risque héréditaire : vers de nouvelles pistes ?Éric Leblanc, Philippe Vennin, Fabrice Narducci — 2014
• Society of Gynecologic Oncology recommendations for the prevention of ovarian cancerJoan L. Walker, C. Bethan Powell, Lee‐may Chen — 2015
• Laparoscopic supracervical hysterectomy with concomitant bilateral salpingectomy--why not?Sebastian Berlit, Benjamin Tuschy, Sven Kehl — 2013
• Opportunistic salpingectomy for ovarian cancer preventionGillian E. Hanley, Jessica N. McAlpine, Janice S. Kwon — 2015
• Early salpingectomy (TUbectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1/2 mutation carriers (TUBA study): a prospective non-randomised multicentre studyMarline G. Harmsen, M.A.D.W. de Jong, Nicoline Hoogerbrugge — 2015
• [Early detection of ovarian cancer: tomorrow? A review].Geneviève Chêne, F Penault–Llorca, Nina Robin — 2013
• Acceptability of Prophylactic Salpingectomy with Delayed Oophorectomy as Risk-Reducing Surgery Among BRCA Mutation CarriersLaura L. Holman, Sue Friedman, Molly S. Daniels — 2014
• Proteomic analyses of serous and endometrioid epithelial ovarian cancers – Cases studies – Molecular insights of a possible histological etiology of serous ovarian cancerRémi Longuespée, Hugo Gagnon, C. Boyon — 2013
• Refractory fallopian tube carcinoma – current perspectives in pathogenesis and managementRussell J. Schilder, Ashwin R. Sama — 2014
• Patient groups that fimbriectomy could reduce high grade serous ovarian cancer incidence.Ioannis Kotsopoulos, Vasileios S Tsapanos — 2013
• BRCA Carriers, Prophylactic Salpingo-Oophorectomy and Menopause: Clinical Management Considerations and RecommendationsAmy Finch, D. Gareth Evans, Steven A. Narod — 2012
• BRCA-Associated Ovarian Cancer: From Molecular Genetics to Risk ManagementGiulia Girolimetti, Anna Myriam Perrone, Donatella Santini — 2014
• Fertility sparing treatment in borderline ovarian tumoursRosa Álvarez — 2015

Related papers

• Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.Bettina Meiser, Phyllis Butow, Alexandra Barratt — 1999
• Perceptions of risk and reward in BRCA1 and BRCA2 mutation carriers choosing salpingectomy for ovarian cancer preventionTalayeh Ghezelayagh, Lauren E. Stewart, Barbara M. Norquist — 2020
• Acceptability of Prophylactic Salpingectomy with Delayed Oophorectomy as Risk-Reducing Surgery Among BRCA Mutation CarriersLaura L. Holman, Sue Friedman, Molly S. Daniels — 2014
• The role of prophylactic oophorectomy in the avoidance of ovarian cancerPeter E. Schwartz — 1992
• Breast and ovarian cancer risk perception after prophylactic salpingo‐oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 geneAmy Finch, Kelly Metcalfe, Jie Lui — 2009
• Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families.Henry T. Lynch, Carrie Snyder, Jane F. Lynch — 2006
• Ovarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 MutationNicole Lugo Santiago, Evan Smith, Mary L. Cox — 2020
• Long-term outcomes following a diagnosis of ovarian cancer at the time of preventive oophorectomy among BRCA1 and BRCA2 mutation carriersJoanne Kotsopoulos, Beth Y. Karlan, Jacek Gronwald — 2020
• High Risk for Ovarian Cancer in a Prospective Series Is Restricted to BRCA1/2 Mutation CarriersLovise Mæhle, Jaran Apold, Torbjørn Paulsen — 2008
• Age-specific ovarian cancer risks among women with a BRCA1 or BRCA2 mutation.Joanne Kotsopoulos, Jacek Gronwald, Beth Y. Karlan — 2018